“`html
Recent Institutional Activity in Ecolab
Several hedge funds have updated their holdings of Ecolab (ECL). Campbell & CO acquired a stake worth $749,000 in Q4. Cetera Advisors increased its position by 84.3%, owning 13,415 shares valued at $3,098,000. Cibc World Markets raised its stake by 527.9%, owning 87,915 shares worth $17,438,000. DZ BANK AG boosted its holdings by 5.9%, with 1,128,977 shares valued at $223,933,000. GAMMA Investing grew its position by 50.9%, now owning 4,922 shares worth $1,171,000. Overall, institutional investors own 74.91% of ECL stocks.
Insider Transactions
Director Victoria Reich sold 393 Ecolab shares at $250 each on September 12, totaling $98,250. She now owns 24,041 shares worth approximately $6,010,250. Conversely, Director David Maclennan purchased 650 shares at $240.41 each on August 2, totaling $156,266, now holding 17,967 shares worth $4,319,446. Company insiders possess 0.04% of ECL stock.
Ecolab Stock Overview
Ecolab shares opened at $253.97, with a market cap of $72.53 billion. The stock has a 12-month low of $156.72 and a high of $256.59. The company reported $1.68 EPS for Q2, surpassing estimates of $1.67, with a 10.95% net margin and revenue of $3.99 billion.
Dividend Announcement
Ecolab announced a quarterly dividend of $0.57, payable on October 15 to shareholders as of September 17, yielding 0.90% with a payout ratio of 42.22%.
Analyst Updates
Analysts have mixed views on ECL. UBS lowered its target from $288 to $276, while Citigroup upgraded its rating to “buy.” The average rating is “Moderate Buy,” with a consensus price target of $267.29.
Ecolab Profile
Ecolab Inc. provides water, hygiene, and infection prevention solutions globally across three segments: Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences.
Related Links
“`
